Magnetic resonance guided high intensity focused ultrasound for uterine fibroids and adenomyosis has no effect on ovarian reserve

References

• Yan L, Huang H, Lin J, et al. High-intensity focused ultrasound treatment for symptomatic uterine fibroids: a systematic review and meta-analysis. Int J Hyperthermia. 2022;39(1):230–238.
   PubMed Web of Science ®Google Scholar
• Muka T, Oliver-Williams C, Kunutsor S, et al. Association of age at onset of menopause and time Since onset of menopause With cardiovascular outcomes, intermediate vascular traits, and All-Cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 2016;1(7):767–776.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106(7):1588–1599.
   PubMed Web of Science ®Google Scholar
• Ruan H, Hu J, Zhao J, et al. Menopause and frailty: a scoping review. Menopause. 2020;27(10):1185–1195.
   Google Scholar
• Cheung VYT, Lam TPW, Jenkins CR, et al. Ovarian reserve After Ultrasound-Guided High-Intensity focused ultrasound for uterine fibroids: preliminary experience. J Obstet Gynaecol Can. 2016;38(4):357–361.
   PubMed Web of Science ®Google Scholar
• Lee JS, Hong GY, Lee KH, et al. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid. Int J Obstet Gy. 2017;124:18–22.
   PubMed Web of Science ®Google Scholar
• Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105(11):3361.
   PubMed Web of Science ®Google Scholar
• Broer SL, Broekmans FJM, Laven JSE, et al. Anti-Müllerian hormone: Ovarian reserve testing and its potential clinical implications. In: Human reproduction update, Vol. 20. Oxford: Oxford University Press; 2014. p. 688–701.
   Google Scholar
• Van Disseldorp J, Lambalk CB, Kwee J, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod. 2010;25(1):221–227.
   PubMed Web of Science ®Google Scholar
• Wong QHY, Anderson RA. The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery. Curr Opin Endocrinol Diabetes Obes. 2018;25(6):391–398.
   PubMedGoogle Scholar
• Landersoe SK, Forman JL, Birch Petersen K, et al. Ovarian reserve markers in women using various hormonal contraceptives. Eur J Contracept Reprod Health Care. 2020;25(1):65–71.
   PubMed Web of Science ®Google Scholar
• Iwase A, Osuka S, Goto M, et al. Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: a review of recent studies. J Obstet Gynaecol Res. 2018;44(6):998–1006.
   PubMed Web of Science ®Google Scholar
• Ji J, Liu J, Chen Y, et al. Analysis of high intensity focused ultrasound in treatment of uterine fibroids on ovarian function and pregnancy outcome. J Clin Ultrasound. 2021;50(2):202–208.
   PubMed Web of Science ®Google Scholar
• Sainio T, Saunavaara J, Komar G, et al. Feasibility of apparent diffusion coefficient in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids – a comparison with the funaki classification. Int J Hyperthermia. 2021;38(1):85–94.
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang J, Chen Y, et al. The effect of ultrasound-guided high-intensity focused ultrasound treatment for cesarean scar pregnancy on ovarian reserve. Int J Hyperthermia. 2021;38(1):1409–1414.
   PubMed Web of Science ®Google Scholar
• Wang HY, Quan S, Zhang RL, et al. Comparison of serum anti-Mullerian hormone levels following hysterectomy and myomectomy for benign gynaecological conditions. Eur J Obstet Gynecol Reprod Biol. 2013;171(2):368–371.
   PubMed Web of Science ®Google Scholar
• Ding Y, Yuan Y, Ding J, et al. Comprehensive assessment of the impact of laparoscopic Ovarian cystectomy on ovarian reserve. J Minim Invasive Gynecol. 2015;22(7):1252–1259.
   PubMed Web of Science ®Google Scholar
• Li H, Yan B, Wang Y, et al. The optimal time of ovarian reserve recovery After laparoscopic unilateral ovarian Non-Endometriotic cystectomy. Front Endocrinol. 2021;12:671225.
   PubMed Web of Science ®Google Scholar
• Sireesha M, Chitra T, Subbaiah M, et al. Effect of laparoscopic Ovarian cystectomy on Ovarian reserve in benign ovarian cysts. J Hum Reprod Sci. 2021;14(1):56–60.
   PubMedGoogle Scholar
• Chang HJ, Han SH, Lee JR, et al. Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels. Fertil Steril. 2010;94(1):343–349.
   PubMed Web of Science ®Google Scholar
• Arthur R, Kachura J, Liu G, et al. Laparoscopic myomectomy versus uterine artery embolization: long-term impact on markers of ovarian reserve. J Obstet Gynaecol Can. 2014;36(3):240–247.
   PubMedGoogle Scholar
• Hehenkamp WJK, Volkers NA, Broekmans FJM, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007;22(7):1996–2005.
   PubMed Web of Science ®Google Scholar
• Atabekoğlu C, Taşkin S, Kahraman K, et al. The effect of total abdominal hysterectomy on serum anti-Müllerian hormone levels: a pilot study. Climacteric. 2012;15(4):393–397.
   PubMed Web of Science ®Google Scholar
• Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, et al. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery. Am J Obstet Gynecol. 2019;220(2):174.e1–174.e13.
   PubMed Web of Science ®Google Scholar
• Dillon KE, Sammel MD, Prewitt M, et al. Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertil Steril. 2013;99(2):477–483.
   PubMed Web of Science ®Google Scholar
• Kim CW, Shim HS, Jang H, et al. The effects of uterine artery embolization on ovarian reserve. Eur J Obstet Gynecol Reprod Biol. 2016;206:172–176.
   PubMed Web of Science ®Google Scholar
• La Marca A, Giulini S, Tirelli A, et al. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod. 2007;22(3):766–771.
   PubMed Web of Science ®Google Scholar